Thrombotic stroke in the anesthetized monkey (Macaca mulatta): Characterization by MRI-a pilot study

Cerebrovascular Diseases

Volumn 33, Issue 4, 2012, Pages 329-339

  Gauberti, Maxime ^a   Obiang, Pauline ^a   Guedin, Pierre ^a,e   Balossier, Anne ^a,b   Gakuba, Clment ^a,c   Diependaele, Anne Sophie ^d   Chazalviel, Laurent ^a   Vivien, Denis ^a   Young, Alan R ^a   Agin, Vronique ^a   Orset, Cyrille ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Service de Neurochirurgie   (France)

^c Service d'Anesthésie et Réanimation   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Animal models; Embolic stroke; Focal ischemia; Methods; Middle cerebral artery occlusion; Monkey; MRI; Thrombin

Indexed keywords

SEVOFLURANE; THROMBIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; CEREBRAL ARTERY DISEASE; DISEASE SEVERITY; END TIDAL CARBON DIOXIDE TENSION; EXPERIMENTAL MONKEY; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HEART RATE; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PRIORITY JOURNAL; REPERFUSION; STROKE; TEMPERATURE MEASUREMENT; THROMBOSIS;

ANESTHESIA; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, INHALATION; ANIMALS; ATRACURIUM; CRANIOTOMY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; KETAMINE; MACACA MULATTA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; METHYL ETHERS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; STROKE; THROMBOEMBOLISM;

EID: 84856843669     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000335309     Document Type: Article

References (49)

1. Alonso de Leciñana M, Díez-Tejedor E, Carceller F, Roda JM: Cerebral ischemia: from animal studies to clinical practice-should the methods be reviewed? Cerebrovasc Dis 2001; 11: 20-30.
2. del Zoppo GJ, Copeland BR, Harker LA, Waltz TA, Zyroff J, Hanson SR, Battenberg E: Experimental acute thrombotic stroke in baboons. Stroke 1986; 17: 1254-1265. (Pubitemid 17008967)
3. Kito G, Nishimura A, Susumu T, Nagata R, Kuge Y, Yokota C, Minematsu K: Experimental thromboembolic stroke in cynomolgus monkey. J Neurosci Methods 2001; 105: 45-53. (Pubitemid 32109224)
4. Green RA, Odergren T, Ashwood T: Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 2003; 24: 402-408. (Pubitemid 36952556)
5. Young AR, Ali C, Duretete A, Vivien D: Neuroprotection and stroke: time for a compromise. J Neurochem 2007; 103: 1302-1309. (Pubitemid 47631819)
6. Marshall JW, Duffin KJ, Green AR, Ridley RM: NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke 2001; 32: 190-198. (Pubitemid 32063845)
7. Strong AJ, Smith SE, Whittington DJ, Meldrum BS, Parsons AA, Krupinski J, Hunter AJ, Patel S: Factors influencing the frequency of fluorescence transients as markers of periinfarct depolarizations in focal cerebral ischemia. Stroke 2000; 31: 214-221.
8. Bihel E, Pro-Sistiaga P, Letourneur A, Toutain J, Saulnier R, Insausti R, Bernaudin M, Roussel S, Touzani O: Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging, histological, and immunohistochemical investigations. J Cereb Blood Flow Metab 2010; 30: 273-285.
9. Freret T, Bouet V, Toutain J, Saulnier R, Pro-Sistiaga P, Bihel E, Mackenzie ET, Roussel S, Schuhmann-Bard P, Touzani O: Intraluminal thread model of focal stroke in the nonhuman primate. J Cereb Blood Flow Metab 2008; 28: 786-796. (Pubitemid 351432790)
10. Jungreis CA, Nemoto E, Boada F, Horowitz MB: Model of reversible cerebral ischemia in a monkey model. AJNR Am J Neuroradiol 2003; 24: 1834-1836. (Pubitemid 37280533)
11. Hamberg LM, Hunter GJ, Maynard KI, Owen C, Morris PP, Putman CM, Ogilvy C, González RG: Functional CT perfusion imaging in predicting the extent of cerebral infarction from a 3-hour middle cerebral arterial occlusion in a primate stroke model. AJNR Am J Neuroradiol 2002; 23: 1013-1021. (Pubitemid 34663450)
12. Zabramski JM, Spetzler RF, Selman WR, Roessmann UR, Hershey LA, Crumrine R, Macko R: Naloxone therapy during focal cerebral ischemia evaluation in a primate model. Stroke 1984; 15: 621-627. (Pubitemid 14090234)
13. Frazee JG, Luo X, Luan GM, Hinton DS, Hovda DA, Shiroishi MS, Barcliff LT: Retrograde transvenous neuroperfusion: a back door treatment for stroke. Stroke 1998; 29: 1912-1916. (Pubitemid 28399987)
14. Touzani O, Young AR, Derlon JM, Baron JC, MacKenzie ET: Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anaesthetized baboons. Brain Res 1997; 767: 17-25. (Pubitemid 27428547)
15. Michenfelder JD, Sundt TM: Cerebral ATP and lactate levels in the squirrel monkey following occlusion of the middle cerebral artery. Stroke 1971; 2: 319-326.
16. Crowell RM, Olsson Y, Klatzo I, Ommaya A: Temporary occlusion of the middle cerebral artery in the monkey: clinical and pathological observations. Stroke 1970; 1: 439-448.
17. Hudgins WR, Garcia JH: Transorbital approach to the middle cerebral artery of the squirrel monkey: a technique for experimental cerebral infarction applicable to ultrastructural studies. Stroke 1970; 1: 107-111.
18. Symon L: Regional cerebrovascular responses to acute ischaemia in normocapnia and hypercapnia: an experimental study in baboons. J Neurol Neurosurg Psychiatry 1970; 33: 756-762.
19. Morawetz RB, DeGirolami U, Ojemann RG, Marcoux FW, Crowell RM: Cerebral blood flow determined by hydrogen clearance during middle cerebral artery occlusion in unanesthetized monkeys. Stroke 1978; 9: 143-149. (Pubitemid 8295689)
20. Dodson RF, Aoyagi M, Chu LW: Ultrastructural changes in subacute cerebral infarction following middle cerebral artery occlusion in the baboon. Cytobios 1975; 13: 97-108.
21. Ott EO, Abraham JA, Meyer JS, Tulleken CA, Mathew NT, Achari AN, Aoyagi M, Dodson RF: Regional cerebral blood flow measured by the gamma camera after direct injection of 133Xe into the distal stump of the occluded middle cerebral artery. Stroke 1975; 6: 376-381.
22. Kuge Y, Yokota C, Tagaya M, Hasegawa Y, Nishimura A, Kito G, Tamaki N, Hashimoto N, Yamaguchi T, Minematsu K: Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke. J Cereb Blood Flow Metab 2001; 21: 202-210. (Pubitemid 32207419)
23. Xie Y, Munekata K, Seo K, Hossmann KA: Effect of autologous clot embolism on regional protein biosynthesis of monkey brain. Stroke 1988; 19: 750-757.
24. Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, Ageyama N, Ono F, Terao K, Yoshikawa Y, Hisatsune T: White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res 2009; 65: 71-78.
25. Watanabe O, Bremer AM, West CR: Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. 1. Angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 1977; 8: 61-70.
26. Bremer AM, Watanabe O, Bourke RS: Artificial embolization of the middle cerebral artery in primates: description of an experimental model with extracranial technique. Stroke 1975; 6: 387-390.
27. Koketsu D, Furuichi Y, Maeda M, Matsuoka N, Miyamoto Y, Hisatsune T: Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemia. Exp Neurol 2006; 199: 92-102.
28. Furuichi Y, Maeda M, Moriguchi A, Sawamoto T, Kawamura A, Matsuoka N, Mutoh S, Yanagihara T: Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates. J Cereb Blood Flow Metab 2003; 23: 1183-1194. (Pubitemid 37229522)
29. Kaku S, Umemura K, Mizuno A, Yano S, Suzuki K, Kawasaki T, Nakashima M: Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis. Eur J Pharmacol 1998; 345: 185-192. (Pubitemid 28212351)
30. Young AR, Sette G, Touzani O, Rioux P, Derlon JM, MacKenzie ET, Baron JC: Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anaesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab 1996; 16: 1176-1188. (Pubitemid 26365369)
31. Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D: Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 2007; 38: 2771-2778. (Pubitemid 47494017)
32. Røhl L, Ostergaard L, Simonsen CZ, Vestergaard-Poulsen P, Andersen G, Sakoh M, Le Bihan D, Gyldensted C: Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001; 32: 1140-1146. (Pubitemid 32825798)
33. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH: Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-2250.
34. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752-2758.
35. Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, Heiss WD: Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005; 36: 980-985. (Pubitemid 40629288)
36. Kranz PG, Eastwood JD: Does diffusionweighted imaging represent the ischemic core? An evidence-based systematic review. AJNR Am J Neuroradiol 2009; 30: 1206-1212.
37. Kane I, Sandercock P, Wardlaw J: Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007; 78: 485-491.
38. Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM, EPITHET Investigators: Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75: 1040-1047.
39. Donnan GA, Baron JC, Ma H, Davis SM: Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009; 8: 261-269.
40. Ebinger M, De Silva DA, Christensen S, Parsons MW, Markus R, Donnan GA, Davis SM: Imaging the penumbra-strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci 2009; 16: 178-187.
41. Solling C, Hjort N, Ashkanian M, Ostergaard L, Andersen G: Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window. Cerebrovasc Dis 2009; 27: 223-229.
42. Susumu T, Yoshikawa T, Akiyoshi Y, Nagata R, Fujiwara M, Kito G: Effects of intra-arterial urokinase on a non-human primate thromboembolic stroke model. J Pharmacol Sci 2006; 100: 278-284.
43. Omura T, Tanaka Y, Miyata N, Koizumi C, Sakurai T, Fukasawa M, Hachiuma K, Minagawa T, Susumo T, Yoshida S, Nakaike S, Okuyama S, Harder DR, Roman RJ: Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. Stroke 2006; 37: 1307-1313. (Pubitemid 43731881)
44. Kleinschnitz C, Braeuninger S, Pham M, Austinat M, Nölte I, Renné T, Nieswandt B, Bendszus M, Stoll G: Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis. Stroke 2008; 39: 1262-1268. (Pubitemid 351440700)
45. Owens AP 3rd, Mackman N: Tissue factor and thrombosis: the clot starts here. Thromb Haemost 2010; 104: 432-439.
46. Carpenter CR, Keim SM, Milne WK, Meurer WJ, Barsan WG: Thrombolytic therapy for acute ischemic stroke beyond three hours. J Emerg Med 2011; 40: 82-92.
47. del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-2948.
48. García-Yébenes I, Sobrado M, Zarruk JG, Castellanos M, Pérez de la Ossa N, Dávalos A, Serena J, Lizasoain I, Moro MA: A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke 2011; 42: 196-203.
49. Zhang Z, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M: A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 1997; 17: 123-135. (Pubitemid 27085835)